Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
20154 | 474 | 20.8 | 50% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
451 | 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO | 16125 |
20154 | 1 | CEFOTETAN DISODIUM//DISULFIRAM LIKE REACTION//HYPOPROTHROMBINEMIA | 474 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CEFOTETAN DISODIUM | authKW | 144943 | 1% | 75% | 3 |
2 | DISULFIRAM LIKE REACTION | authKW | 96626 | 1% | 50% | 3 |
3 | HYPOPROTHROMBINEMIA | authKW | 74800 | 1% | 19% | 6 |
4 | ABNORMAL PROTHROMBINEMIA | authKW | 64420 | 0% | 100% | 1 |
5 | ADP INDUCED AND COLLAGEN INDUCED PLATELET AGGREGATION | authKW | 64420 | 0% | 100% | 1 |
6 | AGR BIOMED SCI | address | 64420 | 0% | 100% | 1 |
7 | ANTRACYCLINS | authKW | 64420 | 0% | 100% | 1 |
8 | CARDIOVASCULAR AND LIPID LOWERING DRUGS | authKW | 64420 | 0% | 100% | 1 |
9 | CEFMINOX SODIUM POSTMARKETING SURVEILLANCE | authKW | 64420 | 0% | 100% | 1 |
10 | CEFOPERAZONE SODIUM AND SULBACTAM SODIUM | authKW | 64420 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 4487 | 56% | 0% | 267 |
2 | Microbiology | 1529 | 24% | 0% | 116 |
3 | Infectious Diseases | 1435 | 17% | 0% | 80 |
4 | Hematology | 146 | 6% | 0% | 29 |
5 | Medicine, General & Internal | 85 | 8% | 0% | 37 |
6 | Surgery | 47 | 8% | 0% | 36 |
7 | Peripheral Vascular Diseases | 44 | 4% | 0% | 17 |
8 | Toxicology | 35 | 3% | 0% | 16 |
9 | Oncology | 30 | 6% | 0% | 30 |
10 | Medicine, Research & Experimental | 13 | 3% | 0% | 15 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AGR BIOMED SCI | 64420 | 0% | 100% | 1 |
2 | CLIN TRIAL ORG PHARMACEUT PROD | 64420 | 0% | 100% | 1 |
3 | CLIN TRIAL ORG PHARMACEUT PROD UNION HOSP | 64420 | 0% | 100% | 1 |
4 | HUMAN PHYSYOL PHARMACOL | 64420 | 0% | 100% | 1 |
5 | NEW MED ENCLAVE | 64420 | 0% | 100% | 1 |
6 | ARNETT HOSP | 21472 | 0% | 33% | 1 |
7 | ESCOLA POLITECN ENGN MET MAT | 21472 | 0% | 33% | 1 |
8 | DENT BASIC EDUC | 10733 | 0% | 8% | 2 |
9 | BALTIMORE | 9201 | 0% | 14% | 1 |
10 | CLIN EXPT HEMOSTASIS HEMOTHER Y TRANSFU | 8051 | 0% | 13% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHEMOTHERAPY-TOKYO | 16867 | 1% | 4% | 7 |
2 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 11308 | 4% | 1% | 18 |
3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 10435 | 9% | 0% | 45 |
4 | VIE MEDICALE AU CANADA FRANCAIS | 9201 | 0% | 14% | 1 |
5 | CHEMIOTERAPIA | 8828 | 1% | 2% | 7 |
6 | JAPANESE JOURNAL OF PHARMACOLOGY | 5864 | 4% | 0% | 20 |
7 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 4549 | 9% | 0% | 41 |
8 | DRUG INTELLIGENCE & CLINICAL PHARMACY | 2835 | 1% | 1% | 7 |
9 | CHEMOTHERAPY | 2526 | 2% | 0% | 10 |
10 | INFECTION | 2455 | 3% | 0% | 12 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SATTLER, FR , WEITEKAMP, MR , SAYEGH, A , BALLARD, JO , (1988) IMPAIRED HEMOSTASIS CAUSED BY BETA-LACTAM ANTIBIOTICS.AMERICAN JOURNAL OF SURGERY. VOL. 155. ISSUE 5A. P. 30-39 | 42 | 82% | 17 |
2 | SHEVCHUK, YM , CONLY, JM , (1990) ANTIBIOTIC-ASSOCIATED HYPOPROTHROMBINEMIA - A REVIEW OF PROSPECTIVE STUDIES, 1966-1988.REVIEWS OF INFECTIOUS DISEASES. VOL. 12. ISSUE 6. P. 1109-1126 | 49 | 60% | 28 |
3 | CHEN, LJ , HSIAO, FY , SHEN, LJ , WU, FLL , TSAY, W , HUNG, CC , LIN, SW , (2016) USE OF HYPOPROTHROMBINEMIA-INDUCING CEPHALOSPORINS AND THE RISK OF HEMORRHAGIC EVENTS: A NATIONWIDE NESTED CASE-CONTROL STUDY.PLOS ONE. VOL. 11. ISSUE 7. P. - | 15 | 79% | 0 |
4 | LIPSKY, JJ , (1988) ANTIBIOTIC-ASSOCIATED HYPOPROTHROMBINEMIA.JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. VOL. 21. ISSUE 3. P. 281-300 | 37 | 67% | 64 |
5 | SCHENTAG, JJ , WELAGE, LS , GRASELA, TH , ADELMAN, MH , (1987) DETERMINANTS OF ANTIBIOTIC-ASSOCIATED HYPOPROTHROMBINEMIA.PHARMACOTHERAPY. VOL. 7. ISSUE 3. P. 80-86 | 31 | 89% | 13 |
6 | SU, MX , LIU, MH , DI, B , HUANG, LL , JIANG, Y , MA, PC , HANG, TJ , (2011) PHARMACOKINETIC DIFFERENCES BETWEEN THE EPIMERS OF CEFOTETAN DISODIUM AFTER SINGLE INTRAVENOUS INJECTION IN HEALTHY CHINESE VOLUNTEERS.EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS. VOL. 36. ISSUE 4. P. 223-228 | 15 | 71% | 1 |
7 | SATTLER, FR , WEITEKAMP, MR , BALLARD, JO , (1986) POTENTIAL FOR BLEEDING WITH THE NEW BETA-LACTAM ANTIBIOTICS.ANNALS OF INTERNAL MEDICINE. VOL. 105. ISSUE 6. P. 924-931 | 23 | 88% | 74 |
8 | BREEN, GA , STPETER, WL , (1997) HYPOPROTHROMBINEMIA ASSOCIATED WITH CEFMETAZOLE.ANNALS OF PHARMACOTHERAPY. VOL. 31. ISSUE 2. P. 180-184 | 16 | 84% | 5 |
9 | MARTIN, C , THOMACHOT, L , ALBANESE, J , (1994) CLINICAL PHARMACOKINETICS OF CEFOTETAN.CLINICAL PHARMACOKINETICS. VOL. 26. ISSUE 4. P. 248-258 | 20 | 74% | 9 |
10 | SMITH, KS , BRICELAND, LL , NIGHTINGALE, CH , QUINTILIANI, R , (1989) FORMULARY CONVERSION OF CEFOXITIN USAGE TO CEFOTETAN - EXPERIENCE AT A LARGE TEACHING HOSPITAL.DICP-THE ANNALS OF PHARMACOTHERAPY. VOL. 23. ISSUE 12. P. 1024-1030 | 22 | 81% | 10 |
Classes with closest relation at Level 1 |